RT Journal Article
SR Electronic
T1 The time is ripe to harmonize global acute febrile illness etiologic investigations
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.05.19.22275321
DO 10.1101/2022.05.19.22275321
A1 Moreira, José
A1 Fernando-Carballo, B. Leticia
A1 Escadafal, Camille
A1 Dittrich, Sabine
A1 Brasil, Patrícia
A1 M Siqueira, André
YR 2022
UL http://medrxiv.org/content/early/2022/05/24/2022.05.19.22275321.abstract
AB We investigated the impact of considering different case definitions of fever as inclusion criteria among participants enrolling in an acute febrile illness investigation and observed that adopting a subjective assessment of fever regardless of specific fever cut-off value accounted for the diversity of clinical fever phenotypes and did not mischaracterize the febrile population.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe Biomarker for Fever-Diagnostic (BFF-Dx) study was funded by the Dutch, Australian and UK governments.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was conducted following the Declaration of Helsinki and the Brazilian National Ethics Research Committee and was approved in August 2018 (IRB approval no:70984617.9.0000.5262).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors